Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2024-05-28 | Reverse | 1:200 |
| 2022-12-20 | Reverse | 1:100 |
| 2019-07-29 | Reverse | 1:30 |
| 2017-11-10 | Reverse | 1:12 |
| 2016-01-25 | Reverse | 1:15 |
Sintx Technologies, Inc. develops and commercializes silicon nitride-based medical and industrial products, including coatings and composites, primarily in the U.S., with a focus on biomedical and antipathogenic applications.

An FDA-cleared silicon nitride medical implant system for reconstructive foot and ankle surgery, marking Sintx's entry into the high-value orthopedic market with their latest and most prominent product.
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
![]() | Product | $150K | $188K ▲ | $300K ▲ | $447K ▲ |
![]() | Grant and Contract | $58K | $160K ▲ | $80K ▼ | $5K ▼ |
Overall rating: C-
| PEER | PRICE | |
|---|---|---|
LFWD | $7.34 | COMPARE |
HSCS | $3.59 | COMPARE |
TNON | $6.17 | COMPARE |
PFSA | $2.54 | COMPARE |
XAIR | $3.19 | COMPARE |
RNAZ | $1.71 | COMPARE |
SSKN | $0.01 | COMPARE |